[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Claritev Corporation (CTEV)

Claritev Corporation (CTEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 369,430
  • Shares Outstanding, K 17,048
  • Annual Sales, $ 965,410 K
  • Annual Income, $ -284,280 K
  • EBIT $ 488 M
  • EBITDA $ 942 M
  • 60-Month Beta 0.76
  • Price/Sales 0.42
  • Price/Cash Flow 1.52
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 139.14% (+12.48%)
  • Historical Volatility 207.43%
  • IV Percentile 96%
  • IV Rank 18.88%
  • IV High 373.73% on 11/28/25
  • IV Low 84.53% on 03/18/26
  • Expected Move (DTE 23) 9.22 (42.56%)
  • Put/Call Vol Ratio 9.42
  • Today's Volume 375
  • Volume Avg (30-Day) 346
  • Put/Call OI Ratio 2.14
  • Today's Open Interest 3,841
  • Open Int (30-Day) 1,652
  • Expected Range 12.45 to 30.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-3.74
  • Number of Estimates 1
  • High Estimate $-3.74
  • Low Estimate $-3.74
  • Prior Year $0.32
  • Growth Rate Est. (year over year) -1,268.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.50 +88.43%
on 05/18/26
31.70 -31.64%
on 05/11/26
-0.24 (-1.10%)
since 04/22/26
3-Month
11.50 +88.43%
on 05/18/26
31.70 -31.64%
on 05/11/26
-1.60 (-6.88%)
since 02/20/26
52-Week
11.50 +88.43%
on 05/18/26
74.07 -70.74%
on 09/08/25
-7.48 (-25.66%)
since 05/22/25

Most Recent Stories

More News
Securities Fraud Investigation Into Claritev Corporation (CTEV) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE: ...

CTEV : 21.67 (-7.98%)
Claritev Corporation (CTEV) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith continues its investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV ) investors concerning the Company’s possible...

CTEV : 21.67 (-7.98%)
Securities Fraud Investigation Into Claritev Corporation (CTEV) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz continues its investigation of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV ) on behalf of investors concerning the Company’s...

CTEV : 21.67 (-7.98%)
CLARITEV CORPORATION INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

The law firm of Kirby McInerney LLP is investigating potential claims against Claritev Corporation (“Claritev” or the “Company”) (NYSE:CTEV). The investigation concerns whether...

CTEV : 21.67 (-7.98%)
Securities Fraud Investigation Into Claritev Corporation (CTEV) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Claritev Corporation (“Claritev” or the...

CTEV : 21.67 (-7.98%)
Claritev Corporation (CTEV) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE:  CTEV ) investors concerning the Company’s possible...

CTEV : 21.67 (-7.98%)
Securities Fraud Investigation Into Claritev Corporation (CTEV) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Claritev Corporation (“Claritev” or the “Company”) (NYSE:  CTEV ) on behalf of investors concerning the Company’s...

CTEV : 21.67 (-7.98%)
Claritev Launches PHCS Novera to Give TPAs More Control Over Network Design Amid Rising Healthcare Costs

New Primary Network Solution Helps Balance Regional Access, National Reach, and Cost Discipline

CTEV : 21.67 (-7.98%)
Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026

Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced...

CTEV : 21.67 (-7.98%)
Claritev Q1 Earnings Call Highlights

Claritev (NYSE:CTEV) reported first-quarter 2026 revenue and adjusted EBITDA ahead of internal expectations, while management said sales momentum and new-market expansion support its full-year outlook.President...

CTEV : 21.67 (-7.98%)

Business Summary

Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 26.90
2nd Resistance Point 25.72
1st Resistance Point 23.70
Last Price 21.67
1st Support Level 20.49
2nd Support Level 19.31
3rd Support Level 17.28

See More

52-Week High 74.07
Fibonacci 61.8% 50.17
Fibonacci 50% 42.78
Fibonacci 38.2% 35.40
Last Price 21.67
52-Week Low 11.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.